Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.230
+0.080 (3.72%)
Sep 17, 2025, 12:52 PM EDT - Market open
Celularity Market Cap
Celularity has a market cap or net worth of $59.52 million as of September 17, 2025. Its market cap has decreased by -9.39% in one year.
Market Cap
59.52M
Enterprise Value
126.68M
1-Year Change
-9.39%
Ranking
Category
Stock Price
$2.23
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $59.52M, a decrease of -83.10%. That is a compound annual growth rate of -25.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 57.39M | 22.71% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | 395.31M | 10.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.99B |
| Johnson & Johnson | 427.05B |
| AbbVie | 379.24B |
| UnitedHealth Group | 315.95B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 229.88B |